Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Trends in Tubulin-Binding Combretastatin A-4 Analogs for Anticancer Drug Development
Paidakula Suresh, Srinivas Nerella, Shravankumar Kankala, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 21, pp. 3748-3773
Closed Access | Times Cited: 19

Showing 19 citing articles:

Recent advances in combretastatin A-4 codrugs for cancer therapy
Kerong Guo, Xin Ma, Jian Li, et al.
European Journal of Medicinal Chemistry (2022) Vol. 241, pp. 114660-114660
Closed Access | Times Cited: 21
Recent advances of antitumor leading compound Erianin: Mechanisms of action and structural modification
Lu Ma, Menglong Li, Yueteng Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115844-115844
Closed Access | Times Cited: 9
N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations
Jian Song, Shenghui Wang, Qiu-Ge Liu, et al.
Chinese Chemical Letters (2024) Vol. 36, Iss. 2, pp. 109678-109678
Closed Access | Times Cited: 2
Design and synthesis of novel imidazole-chalcone derivatives as microtubule protein polymerization inhibitors to treat cervical cancer and reverse cisplatin resistance
Zhengye Liu, Zheng Yang, Mourboul Ablise
Bioorganic Chemistry (2024) Vol. 147, pp. 107310-107310
Closed Access | Times Cited: 2
Synthesis and bioevaluation of novel stilbene-based derivatives as tubulin/HDAC dual-target inhibitors with potent antitumor activities in vitro and in vivo
Huajian Zhu, Wenjian Zhu, Yang Liu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115529-115529
Open Access | Times Cited: 7
Replacing the tropolonic methoxyl group of colchicine with methylamino increases tubulin binding affinity with improved therapeutic index and overcomes paclitaxel cross-resistance
Juanjuan Yang, Dake Song, Bingqian Li, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100951-100951
Closed Access | Times Cited: 6
Synthesis, modeling, and biological evaluation of anti-tubulin indole-substituted furanones
Brianna M. Hurysz, Blake Evans, Reuben N. Laryea, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 90, pp. 129347-129347
Open Access | Times Cited: 4
Smart Stimuli-responsive Alginate Nanogels for Drug Delivery Systems and Cancer Therapy: A Review
Hamid Reza Garshasbi, Seyed Morteza Naghib
Current Pharmaceutical Design (2023) Vol. 29, Iss. 44, pp. 3546-3562
Closed Access | Times Cited: 4
Stilbenes: a promising small molecule modulator for epigenetic regulation in human diseases
Jing Tian, Jin Li, Hongquan Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Ring‐B Modification of Combretastatin A‐4 to Generate Thiazolidine‐2,4‐dione‐1,2,3‐triazole Hybrids as Tubulin Polymerization Inhibitors
Advaitha Vanaparthy, Karthik Bokkala, Narasimha Swamy Thirukovela, et al.
ChemistrySelect (2023) Vol. 8, Iss. 23
Closed Access | Times Cited: 3
Novel Tetrazole Derivatives Targeting Tubulin Endowed with Antiproliferative Activity against Glioblastoma Cells
Laura Gallego‐Yerga, Andrea Jazmín Chiliquinga, Rafael Peláez
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11093-11093
Open Access | Times Cited: 3
Design and Synthesis of Novel Chalcone Derivatives: Anti-Breast Cancer Activity Evaluation and Docking Study
Weihong Lai, Jiaxin Chen, Xinjiao Gao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15549-15549
Open Access | Times Cited: 3
The Development of HDAC and Tubulin Dual-Targeting Inhibitors for Cancer Therapy
Jing Nie, Huina Wu, Yepeng Luan, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 5, pp. 480-490
Closed Access | Times Cited: 2
In vitro results with minimal blood toxicity of a combretastatin A4 analogue
Camila Chagas, Jaqueline Vital Mansano, Emerson Barbosa da Silva, et al.
Investigational New Drugs (2024) Vol. 42, Iss. 3, pp. 318-325
Closed Access
Design, synthesis, and bioevaluation of diarylpyrimidine derivatives as novel microtubule destabilizers
Yutao Xiu, Yujing Zhang, Shanbo Yang, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access
Microtubules as a target of antitumor drugs
М. А. Додохова, I. М. Коtievа, А. В. Сафроненко, et al.
South Russian Journal of Therapeutic Practice (2022) Vol. 3, Iss. 3, pp. 25-31
Open Access | Times Cited: 1
Effect of Hybrid Compounds of Stilbene and Pentadienone on Inhibition of Tubulin Polymerization
Jihyun Park, Dongsoo Koh, Young Han Lee, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 10, pp. 1156-1163
Closed Access
Design, Synthesis, and Anti-tumor Activity of Novel 2-Aryl Benzimidazole Compounds
Xiaohelaiti Haimiti, Wu Wen-Ping, Yiting Gao, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 14, pp. 1644-1651
Closed Access
Design of Podophyllotoxin-based Hybrid Compounds as Potential Anticancer Agents
Hezhen Wang, Xun Sun, Chunyong Wei, et al.
Letters in Drug Design & Discovery (2023) Vol. 21, Iss. 11, pp. 1895-1903
Closed Access
Page 1

Scroll to top